Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
- Large deal TCV of $2.5 billion including 63% net new; Headcount increased by 5,591 - FY25 revenue guidance revised to 4.5%-5.0% Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, delivered strong and broad-based performance with $4,939 million in Q3 revenues, growth…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
Launch of Beyond Tennis : A new generative AI tennis league with AI players and data-driven tournaments Infosys (https://www.infosys.com/) (NSE: INFY), (BSE: INFY), (NYSE: INFY), a global leader in next-generation digital services and consulting, in partnership with Tennis Australia (https://apc01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.tennis.com.au%2F&data=05%7C02%7CShruti.Pai%40infosys.com%7Ce74a953ce42e4341f62a08dd33a3fc68%7C63ce7d592f3e42cda8ccbe764cff5eb6%7C0%7C0%7C63…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
The Autonomous Sperm Selection AI-based Robotic System is Poised to Transform the IVF Market BAIBYS™ (https://www.baibys.com/), a pioneering Israeli startup in AI-powered micro-robotics for Artificial Reproductive Technology (ART), today announced it has received the CE mark for its innovative BAIBYS™ system (https://www.youtube.com/watch?v=Vaa_HlxuAm0). This milestone enables the company to commercialize its autonomous…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
Back to media releases (https://norgine.com/media) Next media release (https://norgine.com/press_release/norgine-receives-positive-chmp-opinion-recommending-approval-of-npj5008-dantrolene-sodium-hemiheptahydrate-for-the-treatment-of-malignant-hyperthermia/) Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, i…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
As part of the EU-funded APRIORA project, drug residues are being analysed. Scientists from the University of Rostock are taking water samples in all weathers. The aim is to use innovative approaches to improve wastewater treatment in Europe. The Warnow seems to be flowing uphill on this cold morning,…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
Sentrycs Concludes a Year of Record Growth with its C-UAS Technology Capable of Addressing the Growing Drone Threat Across Four Continents Sentrycs, a technology leader in the Counter-Unmanned Aerial Systems (C-UAS) industry, announced today its continued progress globally within the public safety market. The company recently closed agreements with two new…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
- First India-headquartered company to receive BCR certification - An accredited data privacy compliance framework for international data transfers from the EU Infosys (https://www.infosys.com/) (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced that it has obtained regulatory approvals for its Binding Corporate Rules…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
Leveraging Infosys Topaz and Google Cloud technology, the center of excellence will foster co-innovation to deliver transformative AI-powered solutions Infosys (https://www.infosys.com/) (NSE: INFY), (BSE: INFY), (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced the launch of a Google Cloud center of excellence, powered by Infosys Topaz…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
ZEISS Group revenue increased to just under 11 billion euros (10.894 billion euros), (up 8% on the prior year) – EBIT 1,444 million euros (prior year: 1,686 million euros, EBIT margin 13%). Mixed development in the segments. High spend on research and development equivalent to 15% of revenue, more than…
Share widget is not set up. Go to Admin » Appearance » Widgets » and move Gabfire Widget: Share Items widget into Archive-Share Widget Zone
- Accord announces that the European Commission (EC has granted marketing authorisation for Imuldosa® (development code: DMB-3115), a biosimilar to Stelara®, indicated for a range of immune medicated inflammatory diseases. - The EC approval follows a positive opinion issued on 19 October 2024 by the Committee for Medicinal Products for Human…